| abstract |
The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotid analogues that can bind pathogenic nucleotide repeats in DNA or RNA. |